Literature DB >> 18676836

MUC1 oncoprotein blocks death receptor-mediated apoptosis by inhibiting recruitment of caspase-8.

Naoki Agata1, Rehan Ahmad, Takeshi Kawano, Deepak Raina, Surender Kharbanda, Donald Kufe.   

Abstract

Stimulation of the death receptor superfamily induces the activation of caspase-8 and thereby the apoptotic response. The MUC1 oncoprotein is aberrantly overexpressed by diverse human malignancies and inhibits stress-induced apoptosis. The present results show that MUC1 blocks activation of caspase-8 and apoptosis in the response of malignant cells to tumor necrosis factor alpha, tumor necrosis factor-related apoptosis-inducing ligand, and Fas ligand. The results show that MUC1 associates constitutively with caspase-8. The MUC1 cytoplasmic domain (MUC1-CD) binds directly to the caspase-8 p18 fragment upstream to the catalytic Cys(360) site. The results also show that MUC1-CD binds to Fas-associated death domain (FADD) at the death effector domain. In nonmalignant epithelial cells, MUC1 interacts with caspase-8 and FADD as an induced response to death receptor stimulation. The functional significance of these interactions is supported by the demonstration that MUC1 competes with caspase-8 for binding to FADD and blocks recruitment of caspase-8 to the death-inducing signaling complex. These findings indicate that MUC1 is of importance to the physiologic regulation of caspase-8 activity and that overexpression of MUC1, as found in human malignancies, could contribute to constitutive inhibition of death receptor signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18676836      PMCID: PMC2536759          DOI: 10.1158/0008-5472.CAN-08-0464

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  52 in total

Review 1.  Apoptosis signaling in lymphocytes.

Authors:  C Scaffidi; S Kirchhoff; P H Krammer; M E Peter
Journal:  Curr Opin Immunol       Date:  1999-06       Impact factor: 7.486

2.  MRIT, a novel death-effector domain-containing protein, interacts with caspases and BclXL and initiates cell death.

Authors:  D K Han; P M Chaudhary; M E Wright; C Friedman; B J Trask; R T Riedel; D G Baskin; S M Schwartz; L Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

3.  Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response.

Authors:  Xiaolong Wei; Hai Xu; Donald Kufe
Journal:  Cancer Cell       Date:  2005-02       Impact factor: 31.743

Review 4.  Death receptors: signaling and modulation.

Authors:  A Ashkenazi; V M Dixit
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

5.  Requirement for caspase-8 in NF-kappaB activation by antigen receptor.

Authors:  Helen Su; Nicolas Bidère; Lixin Zheng; Alan Cubre; Keiko Sakai; Janet Dale; Leonardo Salmena; Razqallah Hakem; Stephen Straus; Michael Lenardo
Journal:  Science       Date:  2005-03-04       Impact factor: 47.728

6.  Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis.

Authors:  H Li; H Zhu; C J Xu; J Yuan
Journal:  Cell       Date:  1998-08-21       Impact factor: 41.582

7.  Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors.

Authors:  X Luo; I Budihardjo; H Zou; C Slaughter; X Wang
Journal:  Cell       Date:  1998-08-21       Impact factor: 41.582

8.  Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death.

Authors:  M P Boldin; T M Goncharov; Y V Goltsev; D Wallach
Journal:  Cell       Date:  1996-06-14       Impact factor: 41.582

9.  Pro-caspase-3 is a major physiologic target of caspase-8.

Authors:  H R Stennicke; J M Jürgensmeier; H Shin; Q Deveraux; B B Wolf; X Yang; Q Zhou; H M Ellerby; L M Ellerby; D Bredesen; D R Green; J C Reed; C J Froelich; G S Salvesen
Journal:  J Biol Chem       Date:  1998-10-16       Impact factor: 5.157

10.  Interaction of glycogen synthase kinase 3beta with the DF3/MUC1 carcinoma-associated antigen and beta-catenin.

Authors:  Y Li; A Bharti; D Chen; J Gong; D Kufe
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

View more
  38 in total

Review 1.  Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells.

Authors:  S Bafna; S Kaur; S K Batra
Journal:  Oncogene       Date:  2010-03-29       Impact factor: 9.867

2.  Prevention of lung injury by Muc1 mucin in a mouse model of repetitive Pseudomonas aeruginosa infection.

Authors:  Tsuyoshi Umehara; Kosuke Kato; Yong Sung Park; Erik P Lillehoj; Hideyuki Kawauchi; Kwang Chul Kim
Journal:  Inflamm Res       Date:  2012-05-29       Impact factor: 4.575

3.  NADPH oxidase and Nrf2 regulate gastric aspiration-induced inflammation and acute lung injury.

Authors:  Bruce A Davidson; R Robert Vethanayagam; Melissa J Grimm; Barbara A Mullan; Krishnan Raghavendran; Timothy S Blackwell; Michael L Freeman; Vanniarajan Ayyasamy; Keshav K Singh; Michael B Sporn; Kiyoshi Itagaki; Carl J Hauser; Paul R Knight; Brahm H Segal
Journal:  J Immunol       Date:  2013-01-07       Impact factor: 5.422

4.  The Tat-conjugated N-terminal region of mucin antigen 1 (MUC1) induces protective immunity against MUC1-expressing tumours.

Authors:  H Yang; N-H Cho; S-Y Seong
Journal:  Clin Exp Immunol       Date:  2009-07-17       Impact factor: 4.330

5.  MUC1-C promotes the suppressive immune microenvironment in non-small cell lung cancer.

Authors:  Audrey Bouillez; Dennis Adeegbe; Caining Jin; Xiufeng Hu; Ashujit Tagde; Maroof Alam; Hasan Rajabi; Kwok-Kin Wong; Donald Kufe
Journal:  Oncoimmunology       Date:  2017-07-05       Impact factor: 8.110

6.  MUC1-C Induces PD-L1 and Immune Evasion in Triple-Negative Breast Cancer.

Authors:  Takahiro Maeda; Masayuki Hiraki; Caining Jin; Hasan Rajabi; Ashujit Tagde; Maroof Alam; Audrey Bouillez; Xiufeng Hu; Yozo Suzuki; Masaaki Miyo; Tsuyoshi Hata; Kunihiko Hinohara; Donald Kufe
Journal:  Cancer Res       Date:  2017-12-20       Impact factor: 12.701

Review 7.  Mucins in cancer: function, prognosis and therapy.

Authors:  Donald W Kufe
Journal:  Nat Rev Cancer       Date:  2009-12       Impact factor: 60.716

Review 8.  MUC1-C activates polycomb repressive complexes and downregulates tumor suppressor genes in human cancer cells.

Authors:  Hasan Rajabi; Masayuki Hiraki; Donald Kufe
Journal:  Oncogene       Date:  2018-01-30       Impact factor: 9.867

9.  MUC1-C oncoprotein functions as a direct activator of the nuclear factor-kappaB p65 transcription factor.

Authors:  Rehan Ahmad; Deepak Raina; Maya Datt Joshi; Takeshi Kawano; Jian Ren; Surender Kharbanda; Donald Kufe
Journal:  Cancer Res       Date:  2009-08-25       Impact factor: 12.701

10.  DDIAS suppresses TRAIL-mediated apoptosis by inhibiting DISC formation and destabilizing caspase-8 in cancer cells.

Authors:  Joo-Young Im; Bo-Kyung Kim; Ji-Young Lee; Seung-Ho Park; Hyun Seung Ban; Kyeong Eun Jung; Misun Won
Journal:  Oncogene       Date:  2017-12-15       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.